APA (7th ed.) Citation

D, S., S, K., H, L., HC, L., J, L., HW, P., . . . HS, K. (2024). PCSK9 stimulates Syk, PKCδ, and NF-κB, leading to atherosclerosis progression independently of LDL receptor. Nature communications, 15(1), 2789. https://doi.org/10.1038/s41467-024-46336-2

Chicago Style (17th ed.) Citation

D, Shin, et al. "PCSK9 Stimulates Syk, PKCδ, and NF-κB, Leading to Atherosclerosis Progression Independently of LDL Receptor." Nature Communications 15, no. 1 (2024): 2789. https://doi.org/10.1038/s41467-024-46336-2.

MLA (9th ed.) Citation

D, Shin, et al. "PCSK9 Stimulates Syk, PKCδ, and NF-κB, Leading to Atherosclerosis Progression Independently of LDL Receptor." Nature Communications, vol. 15, no. 1, 2024, p. 2789, https://doi.org/10.1038/s41467-024-46336-2.